Cardiff Oncology, Inc. (NASDAQ:CRDF) Q4 2023 Earnings Call Transcript February 29, 2024 Cardiff Oncology, Inc. beats earnings expectations. Reported EPS is $-0.21, expectations were $-0.26. CRDF isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to the Cardiff Oncology Fourth […]
Read full NASCAR article on Yahoo Sports
Read all NASCAR articles